These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12678779)

  • 1. Chemical genomics strategy for the discovery of new anticancer agents.
    Jung M; Kim H; Kim M
    Curr Med Chem; 2003 May; 10(9):757-62. PubMed ID: 12678779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probes for chemical genomics by design.
    Zanders ED; Bailey DS; Dean PM
    Drug Discov Today; 2002 Jul; 7(13):711-8. PubMed ID: 12110227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
    Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Kier-Hall topological indices in the QSAR of anticancer drug design.
    Nandi S; Bagchi MC
    Curr Comput Aided Drug Des; 2012 Jun; 8(2):159-70. PubMed ID: 22497470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-protein docking: cancer research at the interface between biology and chemistry.
    Glen RC; Allen SC
    Curr Med Chem; 2003 May; 10(9):763-7. PubMed ID: 12678780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer drug discovery using chemical genomics.
    Sehgal A
    Curr Med Chem; 2003 May; 10(9):749-55. PubMed ID: 12678778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis.
    Bhattacharyya S
    Curr Med Chem; 2001 Oct; 8(12):1383-404. PubMed ID: 11562273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH; Zihlif MA; Taha MO
    Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
    Montaña AM; Batalla C
    Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [G-quadruplex ligands: mechanisms of anticancer action and target binding].
    Il'inskiĭ NS; Varizhuk AM; Beniaminov AD; Puzanov MA; Shchelkina AK; Kaliuzhnyĭ DN
    Mol Biol (Mosk); 2014; 48(6):891-907. PubMed ID: 25845230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology: the next paradigm in drug discovery.
    Hopkins AL
    Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.